Concepedia

Author

Monika Kutyna

Centre for Cancer BiologyORCID

Also Known As

M. Kutyna, Monika M. Kutyna, Monika Kutyna, Monika M Kutyna, Monika M. Kutyna

86

Publications

448

Citations

11

H-Index

20

Concepts

All Affiliations

Centre for Cancer BiologySouth Australian Health and Medical Research InstituteThe University of AdelaideRoyal Adelaide HospitalSouth Australia Pathology
MK

About

Monika Kutyna is an author at Centre for Cancer Biology specializing in health sciences, radiation oncology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

3

3

145

2

Medicine

3

3

145

3

Cell Biology

1

1

36

4

Genetic Medicine

1

1

36

5

Molecular Medicine

1

1

36

Monika Kutyna

×

9

Publications

336

Citations

9

H-Index

YearCitations

The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution

Deepak Singhal, Li Yan A. Wee, Monika Kutyna,

Leukemia

2019

61

Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome

Deepak Singhal, Monika Kutyna, Rakchha Chhetri,

Haematologica

2017

58

Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability

Danièl Thomas, Manhong Wu, Yusuke Nakauchi,

Cancer Discovery

2022

52

Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer

Deepak Singhal, Christopher N Hahn, Simone Feurstein,

Leukemia

2021

48

<i>TP53</i>mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype

Devendra Hiwase, Christopher N Hahn, Elizabeth Ngoc Hoa Tran,

Blood

2022

36

Dynamic assessment of RBC‐transfusion dependency improves the prognostic value of the revised‐IPSS in MDS patients

Devendra Hiwase, Deepak Singhal, Corinna Strupp,

American Journal of Hematology

2017

35

A senescence stress secretome is a hallmark of therapy-related myeloid neoplasm stromal tissue occurring soon after cytotoxic exposure

Monika Kutyna, Chung Hoow Kok, Yoon Lim,

Leukemia

2022

19

<i>IDH</i>-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation

Lih En Hong, Mihir D. Wechalekar, Monika Kutyna,

Blood

2024

15

Evidence-based risk stratification of myeloid neoplasms harboring <i>TP53</i> mutations

Mithun Vinod Shah, Kevin Hung, Anmol Baranwal,

Blood Advances

2025

12

Page 1